The observational Internet survey results pre-published in the American Journal of Gastroenterology reporting an association between use of proton-pump inhibitor (PPI) medicines and self-reported positive tests for COVID-19 among people taking PPIs do not prove cause-and-effect.
Learn about CHPA's current slate of federal legislative priorities including OTC regulatory reform, dietary supplement regulation modernization, supply chain and product integrity, and more.
Understand how CHPA’s member companies are working to replenish supply quickly by directing products where they are needed most. This document also includes information about where parents can find these medicines and additional self-care options to aid in comfort and relief.